# Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk

> **NCT06224530** · NA · RECRUITING · sponsor: **King's College London** · enrollment: 69 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06224530
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-19
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06224530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06224530, "Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06224530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*